• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Application of the new classification for cancer of the cardia.

作者信息

Fein M, Fuchs K H, Ritter M P, Freys S M, Heimbucher J, Staab C, Thiede A

机构信息

Department of Surgery, University of Wuerzburg, Germany.

出版信息

Surgery. 1998 Oct;124(4):707-13; discussion 713-4. doi: 10.1067/msy.1998.91363.

DOI:10.1067/msy.1998.91363
PMID:9780992
Abstract

BACKGROUND

Cancer of the cardia is now topographically classified into three types: type I, with the tumor center in the distal esophagus treated with subtotal esophagectomy; type II, arising at the gastroesophageal junction and treated with distal esophagectomy and either proximal or total gastrectomy; and type III, subcardial cancer treated with extended total gastrectomy. Our objective was to review the new classifications and compare the outcomes in patients grouped and treated according to these classifications.

METHODS

Seventy-four patients with cancer of the cardia--15 with type I, 30 with type II, and 29 with type III cancer--underwent surgical resection at our institution between 1992 and 1997. Postoperative complications, UICC stages, and survival (Kaplan-Meier) were compared.

RESULTS

The majority of patients with type I (73%) or type II (53%) cancer had stage I or II tumors, but only 27% of patients with type III cancer had this tumor stage (P < .05). Overall 30-day mortality was 4% and morbidity was 31%. Curative resections were performed in 73% (54 of 74) of the patients with 3-year survival rates of 72% (type I), 68% (type II), and 61% (type III).

CONCLUSION

The recommended therapy for the different types of cancer of the cardia results in acceptable morbidity, mortality, and survival rates.

摘要

相似文献

1
Application of the new classification for cancer of the cardia.
Surgery. 1998 Oct;124(4):707-13; discussion 713-4. doi: 10.1067/msy.1998.91363.
2
Adenocarcinoma of the Esophagogastric Junction in China according to Siewert's classification.中国食管胃交界腺癌的Siewert分类
Jpn J Clin Oncol. 2006 Jun;36(6):364-7. doi: 10.1093/jjco/hyl042. Epub 2006 Jun 9.
3
Individualized surgical strategies for cancer of the esophagogastric junction.食管胃交界部癌的个体化手术策略
Ann Chir Gynaecol. 2000;89(3):191-8.
4
Classification, diagnosis and surgical treatment of carcinomas of the gastroesophageal junction.胃食管交界部癌的分类、诊断及外科治疗
Hepatogastroenterology. 2001 Sep-Oct;48(41):1231-7.
5
[Extent of radical surgery in cardia carcinoma--esophagectomy or gastrectomy?].[贲门癌根治手术的范围——食管切除术还是胃切除术?]
Langenbecks Arch Chir Suppl Kongressbd. 1996;113:169-72.
6
Adenocarcinoma of the gastric cardia: treatment via a left thoracoabdominal approach.贲门腺癌:经左胸腹联合切口治疗
Am Surg. 2002 Jul;68(7):584-90.
7
Adenocarcinoma of the gastric cardia: what is the optimal surgical approach?贲门腺癌:最佳手术方式是什么?
J Am Coll Surg. 2004 Dec;199(6):880-6. doi: 10.1016/j.jamcollsurg.2004.08.015.
8
[Adenocarcinoma of the proximal stomach and cardia: problems of surgical strategy and technics].[近端胃癌和贲门癌:手术策略与技术问题]
Chir Ital. 1984 Aug;36(4):603-19.
9
Surgical therapy of adenocarcinoma of the esophagogastric junction: analysis of prognostic factors.食管胃交界腺癌的手术治疗:预后因素分析
Hepatogastroenterology. 2005 Jul-Aug;52(64):1110-5.
10
[New classification for adenocarcinoma of the esophagogastric junction in China].[中国食管胃交界腺癌的新分类]
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2007 Feb;32(1):138-43.

引用本文的文献

1
[Efficacy of machine learning models Cox regression model for predicting prognosis of esophagogastric junction adenocarcinoma].[机器学习模型与Cox回归模型预测食管胃交界腺癌预后的效能]
Nan Fang Yi Ke Da Xue Xue Bao. 2023 Jun 20;43(6):952-963. doi: 10.12122/j.issn.1673-4254.2023.06.10.
2
Systematic review with meta-analysis: prevalence of prior and concurrent Barrett's oesophagus in oesophageal adenocarcinoma patients.系统评价与荟萃分析:食管腺癌患者中既往和同时存在 Barrett 食管的患病率。
Aliment Pharmacol Ther. 2020 Jul;52(1):20-36. doi: 10.1111/apt.15760. Epub 2020 May 26.
3
Preoperative assessment of tumor location and station-specific lymph node status in patients with adenocarcinoma of the gastroesophageal junction.
胃食管结合部腺癌患者的肿瘤位置和站特异性淋巴结状态的术前评估。
World J Surg. 2013 Jan;37(1):147-55. doi: 10.1007/s00268-012-1804-9.
4
Issues in the management of the upper third gastric cancer.胃上部三分之一癌症的管理问题
Cancer Res Treat. 2004 Feb;36(1):4-5. doi: 10.4143/crt.2004.36.1.4. Epub 2004 Feb 29.
5
Is adenocarcinoma of the esophagogastric junction different between Japan and western countries? The incidence and clinicopathological features at a Japanese high-volume cancer center.日本与西方国家食管胃交界腺癌有差异吗?日本一家大型癌症中心的发病率及临床病理特征
World J Surg. 2009 Jan;33(1):95-103. doi: 10.1007/s00268-008-9740-4.
6
Clinicopathologic comparison of Siewert type II and III adenocarcinomas of the gastroesophageal junction.胃食管交界部Siewert II型和III型腺癌的临床病理比较
World J Surg. 2006 Mar;30(3):364-71. doi: 10.1007/s00268-005-0434-x.
7
Cancer of the esophagogastric junction: epidemiology and pathogenesis.
J Gastrointest Surg. 2002 Jul-Aug;6(4):516-7. doi: 10.1016/s1091-255x(02)00024-0.
8
Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients.食管胃交界腺癌:基于解剖学/地形学分类的手术治疗结果——1002例连续患者分析
Ann Surg. 2000 Sep;232(3):353-61. doi: 10.1097/00000658-200009000-00007.